conducted the Evaluating Liraglutide in Alzheimers Disease (ELAD) study to assess the effect of the novel GLP-1 analog liraglutide on AD, but they have not yet published their conclusions
To learn more, read Herbal Remedies and Cancer Treatment
Our answer is rarely stop. Its usually some version of: Stay on the therapeutic dose for at least 3 to 6 months past goal weight to consolidate the loss Step down carefully (if appropriate), watch the scale, and make adjustments as needed Extend the interval for patients maintaining well on any dose, high or low
You may experience symptoms of dizziness, lightheadedness, nausea, or a quickened heartbeat
Those with G6PD deficiency, kidney or liver damage/dysfunction, very low platelet count, high blood pressure, and congestive heart failure (CHF) may not qualify